VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3164
ETF rank
โ‚น1.45 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,961
Share price
-0.14%
Change (1 day)
9.20%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of February 2026: 0.35%